Cargando…

Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma

INTRODUCTION: When evaluating MRIs for glioblastoma progression, previous scans are usually included into the review. Nowadays dynamic susceptibility contrast (DSC)-perfusion is an essential component in MR-diagnostics of gliomas, since the extent of hyperperfusion upon first diagnosis correlates wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Steidl, Eike, Filipski, Katharina, Hattingen, Elke, Steinbach, Joachim P., Maurer, Gabriele D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891512/
https://www.ncbi.nlm.nih.gov/pubmed/36724187
http://dx.doi.org/10.1371/journal.pone.0274400
_version_ 1784881147827716096
author Steidl, Eike
Filipski, Katharina
Hattingen, Elke
Steinbach, Joachim P.
Maurer, Gabriele D.
author_facet Steidl, Eike
Filipski, Katharina
Hattingen, Elke
Steinbach, Joachim P.
Maurer, Gabriele D.
author_sort Steidl, Eike
collection PubMed
description INTRODUCTION: When evaluating MRIs for glioblastoma progression, previous scans are usually included into the review. Nowadays dynamic susceptibility contrast (DSC)-perfusion is an essential component in MR-diagnostics of gliomas, since the extent of hyperperfusion upon first diagnosis correlates with gene expression and survival. We aimed to investigate if this initial perfusion signature also characterizes the glioblastoma at time of progression. If so, DSC-perfusion data from the initial diagnosis could be of diagnostic benefit in follow-up assessments. METHODS: We retrospectively identified 65 patients with isocitrate dehydrogenase wildtype glioblastoma who had received technically identical DSC-perfusion measurements at initial diagnosis and at time of first progression. We determined maximum relative cerebral blood volume values (rCBV(max)) by standardized re-evaluation of the data including leakage correction. In addition, the corresponding tissue samples from 24 patients were examined histologically for the maximum vessel density within the tumor. Differences (paired t-test/ Wilcoxon matched pairs test) and correlations (Spearman) between the measurements at both timepoints were calculated. RESULTS: The rCBV(max) was consistently lower at time of progression compared to rCBV(max) at time of first diagnosis (p < .001). There was no correlation between the rCBV(max) values at both timepoints (r = .12). These findings were reflected in the histological examination, with a lower vessel density in progressive glioblastoma (p = .01) and no correlation between the two timepoints (r = -.07). CONCLUSION: Our results suggest that the extent of hyperperfusion in glioblastoma at first diagnosis is not a sustaining tumor characteristic. Hence, the rCBV(max) at initial diagnosis should be disregarded when reviewing MRIs for glioblastoma progression.
format Online
Article
Text
id pubmed-9891512
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-98915122023-02-02 Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma Steidl, Eike Filipski, Katharina Hattingen, Elke Steinbach, Joachim P. Maurer, Gabriele D. PLoS One Research Article INTRODUCTION: When evaluating MRIs for glioblastoma progression, previous scans are usually included into the review. Nowadays dynamic susceptibility contrast (DSC)-perfusion is an essential component in MR-diagnostics of gliomas, since the extent of hyperperfusion upon first diagnosis correlates with gene expression and survival. We aimed to investigate if this initial perfusion signature also characterizes the glioblastoma at time of progression. If so, DSC-perfusion data from the initial diagnosis could be of diagnostic benefit in follow-up assessments. METHODS: We retrospectively identified 65 patients with isocitrate dehydrogenase wildtype glioblastoma who had received technically identical DSC-perfusion measurements at initial diagnosis and at time of first progression. We determined maximum relative cerebral blood volume values (rCBV(max)) by standardized re-evaluation of the data including leakage correction. In addition, the corresponding tissue samples from 24 patients were examined histologically for the maximum vessel density within the tumor. Differences (paired t-test/ Wilcoxon matched pairs test) and correlations (Spearman) between the measurements at both timepoints were calculated. RESULTS: The rCBV(max) was consistently lower at time of progression compared to rCBV(max) at time of first diagnosis (p < .001). There was no correlation between the rCBV(max) values at both timepoints (r = .12). These findings were reflected in the histological examination, with a lower vessel density in progressive glioblastoma (p = .01) and no correlation between the two timepoints (r = -.07). CONCLUSION: Our results suggest that the extent of hyperperfusion in glioblastoma at first diagnosis is not a sustaining tumor characteristic. Hence, the rCBV(max) at initial diagnosis should be disregarded when reviewing MRIs for glioblastoma progression. Public Library of Science 2023-02-01 /pmc/articles/PMC9891512/ /pubmed/36724187 http://dx.doi.org/10.1371/journal.pone.0274400 Text en © 2023 Steidl et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Steidl, Eike
Filipski, Katharina
Hattingen, Elke
Steinbach, Joachim P.
Maurer, Gabriele D.
Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title_full Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title_fullStr Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title_full_unstemmed Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title_short Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
title_sort longitudinal study on mri and neuropathological findings: neither dsc-perfusion derived rcbv(max) nor vessel densities correlate between newly diagnosed and progressive glioblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891512/
https://www.ncbi.nlm.nih.gov/pubmed/36724187
http://dx.doi.org/10.1371/journal.pone.0274400
work_keys_str_mv AT steidleike longitudinalstudyonmriandneuropathologicalfindingsneitherdscperfusionderivedrcbvmaxnorvesseldensitiescorrelatebetweennewlydiagnosedandprogressiveglioblastoma
AT filipskikatharina longitudinalstudyonmriandneuropathologicalfindingsneitherdscperfusionderivedrcbvmaxnorvesseldensitiescorrelatebetweennewlydiagnosedandprogressiveglioblastoma
AT hattingenelke longitudinalstudyonmriandneuropathologicalfindingsneitherdscperfusionderivedrcbvmaxnorvesseldensitiescorrelatebetweennewlydiagnosedandprogressiveglioblastoma
AT steinbachjoachimp longitudinalstudyonmriandneuropathologicalfindingsneitherdscperfusionderivedrcbvmaxnorvesseldensitiescorrelatebetweennewlydiagnosedandprogressiveglioblastoma
AT maurergabrieled longitudinalstudyonmriandneuropathologicalfindingsneitherdscperfusionderivedrcbvmaxnorvesseldensitiescorrelatebetweennewlydiagnosedandprogressiveglioblastoma